Exploring the relationship between patients' information preference style and knowledge acquisition process in a computerized patient decision aid randomized controlled trial

Anna M Sawka, Sharon Straus, Gary Rodin, Richard W Tsang, James D Brierley, Lorne Rotstein, Phillip Segal, Amiram Gafni, Shereen Ezzat, David P Goldstein, Anna M Sawka, Sharon Straus, Gary Rodin, Richard W Tsang, James D Brierley, Lorne Rotstein, Phillip Segal, Amiram Gafni, Shereen Ezzat, David P Goldstein

Abstract

Background: We have shown in a randomized controlled trial that a computerized patient decision aid (P-DA) improves medical knowledge and reduces decisional conflict, in early stage papillary thyroid cancer patients considering adjuvant radioactive iodine treatment. Our objectives were to examine the relationship between participants' baseline information preference style and the following: 1) quantity of detailed information obtained within the P-DA, and 2) medical knowledge.

Methods: We randomized participants to exposure to a one-time viewing of a computerized P-DA (with usual care) or usual care alone. In pre-planned secondary analyses, we examined the relationship between information preference style (Miller Behavioural Style Scale, including respective monitoring [information seeking preference] and blunting [information avoidance preference] subscale scores) and the following: 1) the quantity of detailed information obtained from the P-DA (number of supplemental information clicks), and 2) medical knowledge. Spearman correlation values were calculated to quantify relationships, in the entire study population and respective study arms.

Results: In the 37 P-DA users, high monitoring information preference was moderately positively correlated with higher frequency of detailed information acquisition in the P-DA (r = 0.414, p = 0.011). The monitoring subscale score weakly correlated with increased medical knowledge in the entire study population (r = 0.268, p = 0.021, N = 74), but not in the respective study arms. There were no significant associations with the blunting subscale score.

Conclusions: Individual variability in information preferences may affect the process of information acquisition from computerized P-DA's. More research is needed to understand how individual information preferences may impact medical knowledge acquisition and decision-making.

Figures

Fig. 1
Fig. 1
CONSORT flow diagram

References

    1. Stacey D, Légaré F, Col NF, Bennett CL, Barry MJ, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014;1:CD001431.
    1. O’Brien MA, Whelan TJ, Villasis-Keever M, Gafni A, Charles C, Roberts R, et al. Are cancer-related decision aids effective? A systematic review and meta-analysis. J Clin Oncol. 2009;27:974–85. doi: 10.1200/JCO.2007.16.0101.
    1. Elwyn G, O’Connor AM, Bennett C, Newcombe RG, Politi M, Durand MA, et al. Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi) PLoS One. 2009;4(3):e4705. doi: 10.1371/journal.pone.0004705.
    1. Hoffman AS, Volk RJ, Saarimaki A, Stirling C, Li LC, Härter M, et al. Delivering patient decision aids on the Internet:definitions, theories, current evidence, and emerging research areas. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S13. doi: 10.1186/1472-6947-13-S2-S13.
    1. Zhang Y. The effects of preference for information on consumers’ online health information search behavior. J Med Internet Res. 2013;15(11):e234. doi: 10.2196/jmir.2783.
    1. Williams-Piehota P, Pizarro J, Schneider TR, Mowad L, Salovey P. Matching health messages to monitor-blunter coping styles to motivate screening mammography. Health Psychol. 2005;24(1):58–67. doi: 10.1037/0278-6133.24.1.58.
    1. Lauver DR, Settersten L, Kane JH, Henriques JB. Tailored messages, external barriers, and women’s utilization of professional breast cancer screening over time. Cancer. 2003;97(11):2724–35. doi: 10.1002/cncr.11397.
    1. Kiesler DJ, Auerbach SM. Optimal matches of patient preferences for information, decision-making and interpersonal behavior: evidence, models and interventions. Patient Educ Couns. 2006;61(3):319–41. doi: 10.1016/j.pec.2005.08.002.
    1. Sawka AM, Straus S, Gafni A, Meiyappan S, O’Brien MA, Brierley JD, et al. A usability study of a computerized decision aid to help patients with early stage papillary thyroid carcinoma in decision making on adjuvant radioactive iodine treatment. Patient Educ Couns. 2011;84:e24–7. doi: 10.1016/j.pec.2010.07.038.
    1. Sawka AM, Straus S, Gafni A, Brierley JD, Tsang RW, Rotstein L, et al. How can we meet the information needs of patients with early stage papillary thyroid cancer considering radioactive iodine remnant ablation? Clin Endocrinol (Oxf) 2011;74:419–23. doi: 10.1111/j.1365-2265.2010.03966.x.
    1. Sawka AM, Meiyappan S, David D, Straus S, Gafni A, Brierley JD, et al. A mixed methods evaluation of a computerized decision aid for patients considering radioactive iodine remnant ablation: Developing person-centered medicine for thyroid cancer. Int J Pers Cent Med. 2011;1:559–63.
    1. Sawka AM, Straus S, Brierley JD, Tsang RW, Rotstein L, Rodin G, et al. Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer–a randomized controlled trial. Trials. 2010;11:81. doi: 10.1186/1745-6215-11-81.
    1. Sawka AM, Straus S, Rotstein L, Brierley JD, Tsang RW, Asa S, et al. Randomized controlled trial of a computerized decision aid on adjuvant radioactive iodine treatment for patients with early-stage papillary thyroid cancer. J Clin Oncol. 2012;30:2906–11. doi: 10.1200/JCO.2011.41.2734.
    1. Sawka AM, Goldstein DP, Brierley JD, Tsang RW, Rotstein L, Ezzat S, et al. The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study. PLoS One. 2009;4:e4191. doi: 10.1371/journal.pone.0004191.
    1. Miller SM, Brody DS, Summerton J. Styles of coping with threat: Implications for health. J Pers Soc Psychol. 1988;54:142–8. doi: 10.1037/0022-3514.54.1.142.
    1. Miller SM. Monitoring and blunting: Validation of a questionnaire to assess styles of information seeking under threat. J Pers Soc Psychol. 1987;52:345–53. doi: 10.1037/0022-3514.52.2.345.
    1. Miller SM. Monitoring versus blunting styles of coping with cancer influence the information patients want and need about their disease. Cancer. 1995;76:167–77. doi: 10.1002/1097-0142(19950715)76:2<167::AID-CNCR2820760203>;2-K.
    1. Schulz KF, Altman DG, Moher D, for the CONSORT Group CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Medicine. 2010;8:18. doi: 10.1186/1741-7015-8-18.
    1. Sawka AM, Brierley JD, Tsang RW, Thabane L, Rotstein L, Gafni A, et al. An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer. Endocrinol Metab Clin North Am. 2008;37(2):457–80. doi: 10.1016/j.ecl.2008.02.007.
    1. Sawka AM, Thabane L, Parlea L, Ibrahim-Zada I, Tsang RW, Brierley JD, et al. Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid. 2009;19(5):451–7. doi: 10.1089/thy.2008.0392.
    1. Sawka AM, Lakra DC, Lea J, Alshehri B, Tsang RW, Brierley JD, et al. A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors. Clin Endocrinol (Oxf) 2008;69(3):479–90. doi: 10.1111/j.1365-2265.2008.03222.x.
    1. Sawka AM, Ibrahim-Zada I, Galacgac P, Tsang RW, Brierley JD, Ezzat S, et al. Dietary iodine restriction in preparation for radioactive iodine treatment or scanning in well-differentiated thyroid cancer: a systematic review. Thyroid. 2010;20(10):1129–38. doi: 10.1089/thy.2010.0055.
    1. Sawka AM, Lea J, Alshehri B, Straus S, Tsang RW, Brierley JD, et al. A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors. Clin Endocrinol (Oxf) 2008;68(4):610–7. doi: 10.1111/j.1365-2265.2007.03081.x.
    1. O’Connor AM. User Manual – Decisional Conflict Scale 1993, updated 2005.
    1. O’Connor AM. Validation of a decisional conflict scale. Med Dec Making. 1995;15:25–30. doi: 10.1177/0272989X9501500105.
    1. Ong LM, Visser MR, van Zuuren FJ, Rietbroek RC, Lammes FB, de Haes JC. Cancer patients’ coping styles and doctor-patient communication. Psycho-Oncol. 1999;8:155–66. doi: 10.1002/(SICI)1099-1611(199903/04)8:2<155::AID-PON350>;2-A.
    1. Timmermans LM, van Zuuren FJ, van der Maazen RW, Leer JW, Kraaimaat FW. Monitoring and blunting in palliative and curative radiotherapy consultations. Psycho-Oncol. 2007;16:1111–20. doi: 10.1002/pon.1177.
    1. Cowan C, Hoskins R. Information preferences of women receiving chemotherapy for breast cancer. Eur J Cancer Care (Engl) 2007;16:543–50. doi: 10.1111/j.1365-2354.2007.00782.x.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться